search
Back to results

Mindfulness to Enhance Quality of Life and Support Advance Care Planning (MEANING)

Primary Purpose

Mindfulness, Meditation, Metastatic Cancer

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Mindfulness
Sponsored by
Indiana University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Mindfulness

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria-Patients

  • Patient is at least 18 years of age.
  • Patient is at least 3 weeks post-diagnosis of an incurable (locally advanced or metastatic) solid malignancy.
  • Patient's attending medical oncologist would not be surprised if the patient died in the next 12 months.
  • Patient has not completed a POST form.
  • Patient scores ≥ 7 on the Mini-Mental Adjustment to Cancer cognitive avoidance subscale.
  • Patient is willing and able to consent and travel to the class location for 6 weekly 2-hour sessions.
  • Patient has a family member or close friend eligible and interested in participating in the study.
  • Patient has adequate English fluency for completion of data collection

Inclusion Criteria-Family Care Givers (FCG)

  • FCG is at least 18 years of age.
  • FCG has been invited to participate in the trial with a patient who meets eligibility criteria above.
  • FCG is willing and able to consent and travel to the class location for 6 weekly 2-hour sessions.
  • FCG has adequate English fluency for completion of data collection

Exclusion Criteria-Patients

  • Patient reports a score of > 2 on the Activities and Function item from the Patient Generated Subjective Global Assessment91 (PG-SGA; the patient-reported version of the Eastern Cooperative Oncology Group score).
  • Patient makes 3 or more errors on a validated 6-item cognitive screener or exhibits significant psychiatric or cognitive impairment (e.g., dementia/delirium, retardation, active psychosis) that in the judgment of the investigators would preclude providing informed consent and study participation.
  • Currently receiving hospice care (patients who enroll in hospice during the trial will have the option of continuing trial participation).

Exclusion Criteria-FCGs

• FCG exhibits significant psychiatric or cognitive impairment (e.g., dementia/delirium, retardation, active psychosis) that in the judgment of the investigators would preclude providing informed consent and study participation.

Sites / Locations

  • Indiana University

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Active Comparator

Arm Label

Usual Care

Mindfulness

Arm Description

Participants assigned to Usual Care will continue to receive standard care from their oncology team, including access to supportive care from oncology social workers. At the end of the study, usual care dyads will receive a packet of informational materials on mindfulness meditation, receive a CD with 5 mindfulness meditation practices, and meet with the study interventionist for guidance on how to use the materials and mindfulness recordings to their advantage in coping with cancer-related challenges.

The Mindfulness intervention will consist of six 2-hour sessions that will include guided mindfulness practices, didactics, and group discussion. The course curriculum is modeled on the Mindfulness-Based Stress Reduction program which involves intensive experiential training of participants in secular mindfulness meditation practices (i.e., body scan, sitting meditation, gentle hatha yoga with chair adaptations, compassion meditation), with an emphasis on embodying interpersonal mindfulness in dialogue.

Outcomes

Primary Outcome Measures

Change from baseline in quality of life (QoL) for Patients
QoL for patients will be assessed with the McGill Quality of Life Inventory.
Change from baseline in quality of life (QoL) for Family Caregivers
QoL for family caregivers will be assessed with the Caregiver Quality of Life - Cancer scale (CQoLC).

Secondary Outcome Measures

Change from baseline in advance care planning (ACP) stage of change
ACP stage of change will be assessed by a measure modified from Fried et. al assessing stage of change for 3 advance care planning behaviors (completing a living will, medical power of attorney form, or POLST form; patient only measure).
Change from baseline in advance care planning (ACP) engagement
ACP engagement (self-efficacy, readiness) will be measured using 2 subscales of the Advance Care Planning Engagement Survey (patient only measure).
Change from baseline in caregiver burden
Caregiver burden will be measured using the Zarit Burden Interview (family caregiver measure only)
Change from baseline in avoidant coping
Avoidant coping will be assessed using the Mini-MAC Cognitive Avoidance subscale
Change from baseline in avoidant coping
Avoidant coping will be assessed using the Brief COPE Self-Distraction, Denial, and Behavioral Disengagement subscales
Change from baseline in depressive symptoms
Depressive symptoms will be assessed using the PHQ-8
Change from baseline in anxiety
Anxiety will be assessed using the GAD-7
Change from baseline in spiritual well-being
Spiritual well-being will be measured using the FACIT-SP.
Change from baseline in sleep disturbance
Sleep disturbance will be assessed using the PROMIS Sleep Disturbance.
Change from baseline in family communication
Family communication will be assessed using the Social Constraint Scale
Change from baseline in interpersonal closeness
Interpersonal closeness will be assessed using the Perceived Interpersonal Closeness Scale.
Change from baseline in acceptance of illness
Acceptance of illness will be assessed using the PEACE Scale.
Change from baseline in mindfulness
Mindfulness will be assessed using the FFMQ-SF Non-reactivity to Internal Experience and Acting with Awareness subscales.
Distress Thermometer
Distress will be assessed using the Distress Thermometer.
Intervention satisfaction and helpfulness
Satisfaction and helpfulness with the Mindfulness intervention will be assessed using single-item investigator-created 7- and 10-point Likert scales, respectively (Mindfulness group only).

Full Information

First Posted
August 16, 2017
Last Updated
August 10, 2020
Sponsor
Indiana University
search

1. Study Identification

Unique Protocol Identification Number
NCT03257007
Brief Title
Mindfulness to Enhance Quality of Life and Support Advance Care Planning
Acronym
MEANING
Official Title
Mindfulness to Enhance Quality of Life and Support Advance Care Planning (MEANING): A Randomized Controlled Pilot Trial for Adults With Metastatic Cancer and Their Family Caregivers
Study Type
Interventional

2. Study Status

Record Verification Date
August 2020
Overall Recruitment Status
Completed
Study Start Date
May 9, 2017 (Actual)
Primary Completion Date
December 11, 2017 (Actual)
Study Completion Date
December 11, 2017 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Indiana University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The MEANING trial is a randomized controlled mixed methods pilot designed to compare a novel mindfulness meditation-based intervention (MEANING) to usual care for adults with advanced-stage solid malignancies and their family caregivers.
Detailed Description
Mindfulness meditation practices have reduced emotional distress, avoidant coping, and improved spiritual well-being in adult cancer patients. These beneficial effects may occur through present-moment acceptance of unpleasant thoughts, feelings, and circumstances and adaptive coping through self-awareness, self-regulation, and self-transcendence. Most mindfulness trials in cancer have focused on early-stage survivors; however, preliminary evidence suggests that mindfulness may help reduce distress in patients with advanced cancer and their family caregivers (FCGs). Sixty patients with an advanced-stage solid malignancy and their FCGs (60 dyads) will be randomized in equal numbers to receive either the 6-week mindfulness intervention or usual care. Both groups will receive standard cancer care throughout the study period. Dyads randomized to the mindfulness arm will learn mindfulness meditation practices (e.g., body scan, sitting meditation) and mindful communication practices to enhance quality of life, support advance care planning engagement, and improve a variety of secondary outcomes. The study will use a mixed methods 2-arm randomized design to examine the effects of the mindfulness intervention compared to usual care and seek to explain trial results using insights gleaned from post-intervention qualitative interviews.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Mindfulness, Meditation, Metastatic Cancer, Quality of Life, Advance Care Planning, Palliative Care, Family Caregiver, Supportive Care

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Participants will be assigned in equal numbers using block randomization to the mindfulness intervention or usual care. The course curriculum for the mindfulness intervention is modeled on the Mindfulness-Based Stress Reduction program which involves intensive experiential training of participants in secular mindfulness meditation practices (i.e., body scan, sitting meditation, gentle hatha yoga with chair adaptations, compassion meditation), with an emphasis on embodying interpersonal mindfulness in dialogue.
Masking
None (Open Label)
Masking Description
Participants are blind to study hypotheses.
Allocation
Randomized
Enrollment
108 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Usual Care
Arm Type
No Intervention
Arm Description
Participants assigned to Usual Care will continue to receive standard care from their oncology team, including access to supportive care from oncology social workers. At the end of the study, usual care dyads will receive a packet of informational materials on mindfulness meditation, receive a CD with 5 mindfulness meditation practices, and meet with the study interventionist for guidance on how to use the materials and mindfulness recordings to their advantage in coping with cancer-related challenges.
Arm Title
Mindfulness
Arm Type
Active Comparator
Arm Description
The Mindfulness intervention will consist of six 2-hour sessions that will include guided mindfulness practices, didactics, and group discussion. The course curriculum is modeled on the Mindfulness-Based Stress Reduction program which involves intensive experiential training of participants in secular mindfulness meditation practices (i.e., body scan, sitting meditation, gentle hatha yoga with chair adaptations, compassion meditation), with an emphasis on embodying interpersonal mindfulness in dialogue.
Intervention Type
Behavioral
Intervention Name(s)
Mindfulness
Intervention Description
The Mindfulness intervention sessions are designed to cultivate present-moment awareness in everyday life to facilitate adaptive and non-reactive relating to thoughts, feelings, and bodily sensations. Participants will be provided with 10-20 minute audio recordings of each of 5 mindfulness practices covered in class, recorded in the facilitator's voice. Participants will be encouraged to practice mindfulness at home 10-20 minutes per day, 6 days per week. Participants will be provided with weekly diaries on which to record type and amount of home practice of mindfulness skills.
Primary Outcome Measure Information:
Title
Change from baseline in quality of life (QoL) for Patients
Description
QoL for patients will be assessed with the McGill Quality of Life Inventory.
Time Frame
Baseline, 6 weeks, and 10 weeks
Title
Change from baseline in quality of life (QoL) for Family Caregivers
Description
QoL for family caregivers will be assessed with the Caregiver Quality of Life - Cancer scale (CQoLC).
Time Frame
Baseline, 6 weeks, and 10 weeks
Secondary Outcome Measure Information:
Title
Change from baseline in advance care planning (ACP) stage of change
Description
ACP stage of change will be assessed by a measure modified from Fried et. al assessing stage of change for 3 advance care planning behaviors (completing a living will, medical power of attorney form, or POLST form; patient only measure).
Time Frame
Baseline, 6 weeks, and 10 weeks
Title
Change from baseline in advance care planning (ACP) engagement
Description
ACP engagement (self-efficacy, readiness) will be measured using 2 subscales of the Advance Care Planning Engagement Survey (patient only measure).
Time Frame
Baseline, 6 weeks, and 10 weeks
Title
Change from baseline in caregiver burden
Description
Caregiver burden will be measured using the Zarit Burden Interview (family caregiver measure only)
Time Frame
Baseline, 6 weeks, and 10 weeks
Title
Change from baseline in avoidant coping
Description
Avoidant coping will be assessed using the Mini-MAC Cognitive Avoidance subscale
Time Frame
Baseline, 6 weeks, and 10 weeks
Title
Change from baseline in avoidant coping
Description
Avoidant coping will be assessed using the Brief COPE Self-Distraction, Denial, and Behavioral Disengagement subscales
Time Frame
Baseline, 6 weeks, and 10 weeks
Title
Change from baseline in depressive symptoms
Description
Depressive symptoms will be assessed using the PHQ-8
Time Frame
Baseline, 6 weeks, and 10 weeks
Title
Change from baseline in anxiety
Description
Anxiety will be assessed using the GAD-7
Time Frame
Baseline, 6 weeks, and 10 weeks
Title
Change from baseline in spiritual well-being
Description
Spiritual well-being will be measured using the FACIT-SP.
Time Frame
Baseline, 6 weeks, and 10 weeks
Title
Change from baseline in sleep disturbance
Description
Sleep disturbance will be assessed using the PROMIS Sleep Disturbance.
Time Frame
Baseline, 6 weeks, and 10 weeks
Title
Change from baseline in family communication
Description
Family communication will be assessed using the Social Constraint Scale
Time Frame
Baseline, 6 weeks, and 10 weeks
Title
Change from baseline in interpersonal closeness
Description
Interpersonal closeness will be assessed using the Perceived Interpersonal Closeness Scale.
Time Frame
Baseline, 6 weeks, and 10 weeks
Title
Change from baseline in acceptance of illness
Description
Acceptance of illness will be assessed using the PEACE Scale.
Time Frame
Baseline, 6 weeks, and 10 weeks
Title
Change from baseline in mindfulness
Description
Mindfulness will be assessed using the FFMQ-SF Non-reactivity to Internal Experience and Acting with Awareness subscales.
Time Frame
Baseline, 6 weeks, and 10 weeks
Title
Distress Thermometer
Description
Distress will be assessed using the Distress Thermometer.
Time Frame
Baseline, 6 weeks, and 10 weeks
Title
Intervention satisfaction and helpfulness
Description
Satisfaction and helpfulness with the Mindfulness intervention will be assessed using single-item investigator-created 7- and 10-point Likert scales, respectively (Mindfulness group only).
Time Frame
6 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria-Patients Patient is at least 18 years of age. Patient is at least 3 weeks post-diagnosis of an incurable (locally advanced or metastatic) solid malignancy. Patient's attending medical oncologist would not be surprised if the patient died in the next 12 months. Patient has not completed a POST form. Patient scores ≥ 7 on the Mini-Mental Adjustment to Cancer cognitive avoidance subscale. Patient is willing and able to consent and travel to the class location for 6 weekly 2-hour sessions. Patient has a family member or close friend eligible and interested in participating in the study. Patient has adequate English fluency for completion of data collection Inclusion Criteria-Family Care Givers (FCG) FCG is at least 18 years of age. FCG has been invited to participate in the trial with a patient who meets eligibility criteria above. FCG is willing and able to consent and travel to the class location for 6 weekly 2-hour sessions. FCG has adequate English fluency for completion of data collection Exclusion Criteria-Patients Patient reports a score of > 2 on the Activities and Function item from the Patient Generated Subjective Global Assessment91 (PG-SGA; the patient-reported version of the Eastern Cooperative Oncology Group score). Patient makes 3 or more errors on a validated 6-item cognitive screener or exhibits significant psychiatric or cognitive impairment (e.g., dementia/delirium, retardation, active psychosis) that in the judgment of the investigators would preclude providing informed consent and study participation. Currently receiving hospice care (patients who enroll in hospice during the trial will have the option of continuing trial participation). Exclusion Criteria-FCGs • FCG exhibits significant psychiatric or cognitive impairment (e.g., dementia/delirium, retardation, active psychosis) that in the judgment of the investigators would preclude providing informed consent and study participation.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Shelley A Johns, PsyD
Organizational Affiliation
Indiana University School of Medicine
Official's Role
Principal Investigator
Facility Information:
Facility Name
Indiana University
City
Indianapolis
State/Province
Indiana
ZIP/Postal Code
46202
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
Undecided

Learn more about this trial

Mindfulness to Enhance Quality of Life and Support Advance Care Planning

We'll reach out to this number within 24 hrs